YU42172B - Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide - Google Patents

Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide

Info

Publication number
YU42172B
YU42172B YU50/79A YU5079A YU42172B YU 42172 B YU42172 B YU 42172B YU 50/79 A YU50/79 A YU 50/79A YU 5079 A YU5079 A YU 5079A YU 42172 B YU42172 B YU 42172B
Authority
YU
Yugoslavia
Prior art keywords
orthdanizamide
sulphonyl
amino
alkyl
obtaining new
Prior art date
Application number
YU50/79A
Other languages
English (en)
Other versions
YU5079A (en
Inventor
M Thoominet
J Acher
J C Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of YU5079A publication Critical patent/YU5079A/xx
Publication of YU42172B publication Critical patent/YU42172B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
YU50/79A 1978-01-20 1979-01-11 Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide YU42172B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (2)

Publication Number Publication Date
YU5079A YU5079A (en) 1983-06-30
YU42172B true YU42172B (en) 1988-06-30

Family

ID=9203689

Family Applications (2)

Application Number Title Priority Date Filing Date
YU50/79A YU42172B (en) 1978-01-20 1979-01-11 Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide
YU254/83A YU41278B (en) 1978-01-20 1983-02-04 Process for obtaining new derivatives of 4-amino-5-alkyl-sulfonyl-orthoanisamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU254/83A YU41278B (en) 1978-01-20 1983-02-04 Process for obtaining new derivatives of 4-amino-5-alkyl-sulfonyl-orthoanisamide

Country Status (42)

Country Link
US (2) US4294828A (cs)
JP (1) JPS6049192B2 (cs)
AR (2) AR221354A1 (cs)
AT (1) AT377977B (cs)
AU (1) AU528561B2 (cs)
BE (1) BE872585A (cs)
BG (2) BG31496A3 (cs)
CA (1) CA1101430A (cs)
CH (1) CH637927A5 (cs)
CS (1) CS226181B2 (cs)
CY (1) CY1201A (cs)
DD (1) DD141520A5 (cs)
DE (1) DE2901181C2 (cs)
DK (1) DK158346C (cs)
EG (1) EG14045A (cs)
ES (2) ES476755A1 (cs)
FI (1) FI71126C (cs)
FR (1) FR2415099A1 (cs)
GB (2) GB2012765B (cs)
GR (1) GR64431B (cs)
HK (1) HK12184A (cs)
HU (1) HU179793B (cs)
IE (1) IE47798B1 (cs)
IL (1) IL56411A (cs)
IN (1) IN150226B (cs)
IT (1) IT1164655B (cs)
LU (1) LU80786A1 (cs)
MC (1) MC1232A1 (cs)
MX (2) MX7623E (cs)
NL (1) NL191707C (cs)
NO (1) NO151320C (cs)
NZ (1) NZ189378A (cs)
OA (1) OA06156A (cs)
PH (2) PH15725A (cs)
PL (2) PL116532B1 (cs)
PT (1) PT69068A (cs)
RO (2) RO76393A (cs)
SE (2) SE448874B (cs)
SU (1) SU820659A3 (cs)
YU (2) YU42172B (cs)
ZA (1) ZA79219B (cs)
ZM (1) ZM579A1 (cs)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
ZA818221B (en) * 1980-12-12 1982-10-27 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP1633400A2 (en) * 2003-05-16 2006-03-15 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
JP2007537232A (ja) * 2004-05-11 2007-12-20 ファイザー・プロダクツ・インク 非定型抗精神病薬と５−ｈｔ１ｂ受容体拮抗薬の組合せ
GT200600161A (es) * 2005-04-22 2007-03-14 Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
EP2321011A1 (en) * 2008-06-25 2011-05-18 Pfizer Inc. Diaryl compounds and uses thereof
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
GB201004020D0 (en) 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
BR112012031959A2 (pt) 2010-06-17 2015-09-22 Lupin Ltd um processo aperfeiçoado para preparação de amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN110248655B (zh) 2016-11-28 2023-07-07 Lb制药公司 精神药剂及其用途
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
MX2020005517A (es) 2017-12-05 2020-11-09 Sunovion Pharmaceuticals Inc Formas cristalinas y metodos de produccion de las mismas.
CN118593482A (zh) 2017-12-05 2024-09-06 赛诺维信制药公司 非外消旋混合物及其用途
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
US11160758B2 (en) 2019-06-04 2021-11-02 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof
USD1047552S1 (en) * 2021-04-23 2024-10-22 Krueger International, Inc. Furniture leg with frame
CN116003304A (zh) * 2023-02-08 2023-04-25 浙江皓华制药有限公司 一种氨磺必利的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (cs) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (en) * 1975-02-07 1978-07-21 Soc Et Scient Et Ind Substd. N-(1-benzylpyrrolidinyl-2-alkyl)benzamides - used as antiemetics, anti-ulcer agents and CNS active
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
IE42210B1 (en) * 1974-12-18 1980-06-18 Synthelabo 2-methoxy-benzamide derivatives

Also Published As

Publication number Publication date
AR221354A1 (es) 1981-01-30
US4294828A (en) 1981-10-13
PH15725A (en) 1983-03-18
IE790092L (en) 1979-07-20
YU5079A (en) 1983-06-30
SE7900380L (sv) 1979-07-21
SE460968B (sv) 1989-12-11
BG31497A3 (bg) 1982-01-15
DD141520A5 (de) 1980-05-07
PL116532B1 (en) 1981-06-30
IE47798B1 (en) 1984-06-27
PL212899A1 (cs) 1980-01-14
AR220574A1 (es) 1980-11-14
NZ189378A (en) 1983-03-15
GB2012765B (en) 1982-09-08
PT69068A (fr) 1979-02-01
AU4337379A (en) 1979-07-26
FI71126C (fi) 1986-11-24
SE8603773L (sv) 1986-09-09
NO790180L (no) 1979-07-23
RO80311A (ro) 1982-12-06
DK158346B (da) 1990-05-07
CS226181B2 (en) 1984-03-19
SE448874B (sv) 1987-03-23
US4401822A (en) 1983-08-30
LU80786A1 (fr) 1979-09-07
FI71126B (fi) 1986-08-14
MC1232A1 (fr) 1979-10-26
IN150226B (cs) 1982-08-21
ZA79219B (en) 1980-01-30
IT7947706A0 (it) 1979-01-18
IL56411A (en) 1982-09-30
DE2901181A1 (de) 1979-07-26
IL56411A0 (en) 1979-03-12
GR64431B (en) 1980-03-21
GB2012765A (en) 1979-08-01
NO151320C (no) 1985-04-17
CY1201A (en) 1983-12-31
CH637927A5 (fr) 1983-08-31
ATA39879A (de) 1983-12-15
EG14045A (en) 1983-09-30
RO76393A (ro) 1981-03-30
AU528561B2 (en) 1983-05-05
NL191707B (nl) 1995-12-01
OA06156A (fr) 1981-06-30
MX5793E (es) 1984-07-19
BE872585A (fr) 1979-06-07
DK158346C (da) 1990-10-08
JPS6049192B2 (ja) 1985-10-31
FI790182A7 (fi) 1979-07-21
SE8603773D0 (sv) 1986-09-09
PH22287A (en) 1988-07-22
CA1101430A (en) 1981-05-19
SU820659A3 (ru) 1981-04-07
NL191707C (nl) 1996-04-02
HK12184A (en) 1984-02-24
GB2083458A (en) 1982-03-24
AT377977B (de) 1985-05-28
ES476755A1 (es) 1979-06-01
GB2083458B (en) 1983-03-09
MX7623E (es) 1990-03-27
DE2901181C2 (de) 1984-07-19
YU25483A (en) 1983-10-31
BG31496A3 (bg) 1982-01-15
FR2415099A1 (fr) 1979-08-17
FR2415099B1 (cs) 1981-02-20
NO151320B (no) 1984-12-10
JPS54145658A (en) 1979-11-14
PL118151B1 (en) 1981-09-30
YU41278B (en) 1986-12-31
NL7900457A (nl) 1979-07-24
ES477782A1 (es) 1979-09-16
HU179793B (en) 1982-12-28
ZM579A1 (en) 1979-12-21
DK20979A (da) 1979-07-21
IT1164655B (it) 1987-04-15

Similar Documents

Publication Publication Date Title
YU25483A (en) Process for obtaining new derivatives of 4-amino-5-alkyl-sulfonyl-orthoanisamide
YU42655B (en) Process for obtaining derivatives of carboxialkyldipeptides
YU67183A (en) Process for obtaining new derivatives of 6-beta-hydroxyalkyl penicillinates
RO83052B (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
YU16183A (en) Process for obtaining new heterocyclic derivatives
PT69202A (en) Process for preparing of 9-amino-dibenzopyrans
HU186344B (en) Process for prodiction of solid cianur-chlorid
YU136880A (en) Process for obtaining new derivatives of 3-vinyl-cephalosporin
YU84179A (en) Process for obtaining 2-aminopyridone derivatives
YU80179A (en) Process for obtaining lysergol derivatives
YU42653B (en) Process for obtaining n-benzylhaloacetamide derivatives
YU187879A (en) Process for obtaining derivatives of phenyliminomethyl pyridine
HU178397B (en) Process for preparing substituted derivatives of steroid-spiro-oxazolidione derivatives
YU278580A (en) Process for preparing new derivatives of 1-oxadethiacephalosporin
GR64429B (en) Method for the preparation of new arylaminoimidazolin derivatives
YU43123B (en) Process for obtaining substituted derivatives of acylcarbamides
YU250379A (en) Process for obtaining 2-amino-or 2-thio-substituted derivatives of 4,5-diphenyl-oxazole
YU312378A (en) Process for obtaining 4-deoxy-4-arylglyoxamido-and aroylthioformamido derivatives of oleandomycin
YU54583A (en) Process for obtaining new cephalosporin derivatives
YU20879A (en) Process for obtaining prostaglanid derivatives
EG13413A (en) Process for preparing of benzodiazeptine derivatives
YU147879A (en) Process for obtaining new heterocyclic derivatives
YU110279A (en) Process for obtaining new thiole derivatives of imidazole
EG13225A (en) Process for preparing of carbazales
KR780000694B1 (en) Process for preparation of phyrazol-5-ones